Keyphrases
History of Myocardial Infarction
100%
Thrombotic Events
100%
Vorapaxar
100%
Adjunctive Therapy
100%
Acute Myocardial Infarction
80%
Adverse Cardiac Events
40%
Atherothrombotic Disease
40%
Bleeding Risk
20%
Oral Antiplatelet Agents
20%
Risk Stratification System
20%
Previous History
20%
Stroke History
20%
Adenosine Diphosphate Receptor Antagonist
20%
Intracranial Bleeding
20%
Transient Ischemic Attack
20%
Low Risk
20%
Major Bleeding
20%
Pharmacological Intervention
20%
Atherosclerotic Disease
20%
High Risk of Bleeding
20%
Thrombotic Risk
20%
Platelet Activation
20%
Antithrombotic Agents
20%
Thrombus Formation
20%
Clinical Practice
20%
Acetylsalicylic Acid
20%
Net Clinical Benefit
20%
Stroke Ischemic
20%
Individualized Risk
20%
Protease-activated receptor-1 Antagonists
20%
High Risk
20%
Thrombotic
20%
Bleeding Tendency
20%
Dual Antiplatelet Therapy
20%
Medicine and Dentistry
Adjuvant Therapy
100%
Vorapaxar
100%
Myocardial Infarction
100%
Acute Heart Infarction
80%
Disease
60%
Adenosine Diphosphate
20%
Acetylsalicylic Acid
20%
Risk Stratification
20%
Cerebral Hemorrhage
20%
Blood Clotting
20%
Antithrombotic Agent
20%
Apoplexy
20%
Bleeding Diathesis
20%
Antiplatelet
20%
Proteinase Activated Receptor 1
20%
Antiplatelet Drug
20%
Receptor Antagonist
20%
Transient Ischemic Attack
20%
Thrombocyte Activation
20%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
Vorapaxar
100%
Acute Heart Infarction
80%
Disease
60%
Antiplatelet
20%
Acetylsalicylic Acid
20%
Antithrombocytic Agent
20%
Thrombus
20%
Receptor Antagonist
20%
Proteinase Activated Receptor 1
20%
Transient Ischemic Attack
20%
Cerebrovascular Accident
20%
Anticoagulant Agent
20%
Bleeding Tendency
20%
Brain Hemorrhage
20%
Adenosine Diphosphate
20%